Since we have two trials, we have two visual abstracts from the IPNA JC team, and NSMC faculty, Md Abdul Qader and S. Sudha Mannemuddhu
In addition, we also have Spanish versions! Thanks to Franklin Loachamin and Juan Kupferman for translating them:
Day 3 : yet another IgA trial, and we are back with some flozin news: in ADPKD, their effect on hemoglobin, and on BP (with finerenone)
Day 2 was less exciting: we cover 1 IgA trial (Ravulizumab) along with another calcimimetic, and a pentoxifylline meta-analysis.
Day of Kidney Week 2026. The NephJC crew discusses 6 studies, including some blockbustr IgA news.
This week, we will discuss whether decreased donor transplantation improves mortality in all patients. In this target trial emulation standard donor, extended donor, donation after brain death and donation after cardiac death outcomes are compared across age groups with different co-morbid conditions.
Since we have two trials, we have two visual abstracts from the IPNA JC team, and NSMC faculty, Md Abdul Qader and S. Sudha Mannemuddhu
In addition, we also have Spanish versions! Thanks to Franklin Loachamin and Juan Kupferman for translating them:
AURORA-1, the placebo controlled RCT of voclosporin in lupus nephritis is another NephJC discussion that is now available as a Kidney Medicine manuscript. Bourne Auguste, Jade Teakell, and Avinash Rao Ullur did a great job on this. Take a look.
CONFIRM, the placebo controlled RCT of Terlipressin in HRS is another NephJC discussion that is now available as a Kidney Medicine manuscript. Jamie Willows and Alicja Rydzewska-Rosołowska did a great job on this. Take a look.
LANDMARK is the latest NephJC to be converted to a Kidney Medicine Manuscript. Great work by Carlo Nemesio Trinidad, Melisha Hanna and Sharanya Ramesh. Take a look.
Have you ever missed a #NephJC chat and wanted a rapid catch-up?
Then look out for our new tweetorials! Find the first one at the link.
Welcome to #TenTweetNephJC
— Nephrology Jrnl Club (@NephJC) January 16, 2022
✳️ Catch the key points, in 10 tweets ✳️
Up first - has an antibody that induces Minimal Change Disease finally been found? pic.twitter.com/A1Rt81NsJf
Jade Teakell did great work on the visual abstract for this week’s discussion.
Hanging out with the nephrologist pic.twitter.com/T22YdFbd4S
— Dr. Glaucomflecken (@DGlaucomflecken) February 28, 2021
Dr. Aarthi designed this nice visual abstract for this week’s chat.
Thank Mike Turk for this week’s visual abstract of the CLICK Study
Nice visual abstract on this week’s NephJC by Abdul Qader